Literature DB >> 2522691

NAD+ levels and glucose uptake of cultured human epidermal cells exposed to sulfur mustard.

M A Mol1, A M van de Ruit, A W Kluivers.   

Abstract

In cultured human epidermal cells exposure to the vesicant sulfur mustard (HD) causes a decrease of the NAD+ content, which depends on the dose and the time period between exposure to HD and NAD+ measurement. Presumably, this NAD+ loss is due to activation of the enzyme NAD:protein ADP-ribosyltransferase (ADPRT) and may lead to glycolysis inhibition, disturbance of energy metabolism, and eventually cell death. Since prevention of this NAD+ depletion could lead to cell survival, HD-exposed cultures have been incubated with nicotinamide, a precursor of NAD+ and an inhibitor of ADPRT. Although a reduction in NAD+ levels of the cultures can be prevented, the uptake of glucose, which was taken as a measure for cellular viability, appears to be inhibited in cultures in which the NAD+ levels are at the 100% level at 4 hr after exposure. Therefore, prophylactic or therapeutic measures that are focused on maintenance of NAD+ levels in order to preserve energy supplies do not protect human epidermal cells in culture that have been exposed to HD. These experiments indicate that mechanisms other than NAD+ depletion may play an important role in HD-induced cell injury in human skin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522691     DOI: 10.1016/0041-008x(89)90143-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

Review 1.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

2.  Toxic effects of mechlorethamine on mammalian respiratory mucociliary epithelium in primary culture.

Authors:  I Giuliani; E Boivieux-Ulrich; O Houcine; C Guennou; F Marano
Journal:  Cell Biol Toxicol       Date:  1994-08       Impact factor: 6.691

3.  Glyceraldehyde-3-phosphate dehydrogenase as a biochemical marker of cytotoxicity by vinyl sulfones in cultured murine spleen lymphocytes.

Authors:  D S Choi; Y B Kim; Y H Lee; S H Cha; D E Sok
Journal:  Cell Biol Toxicol       Date:  1995-02       Impact factor: 6.691

4.  Effects of specific inhibitors of cellular functions on sulfur mustard-induced cell death.

Authors:  E T Clayson; S A Kelly; H L Meier
Journal:  Cell Biol Toxicol       Date:  1993 Apr-Jun       Impact factor: 6.691

5.  Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies.

Authors:  John S Graham; Robert P Chilcott; Paul Rice; Stephen M Milner; Charles G Hurst; Beverly I Maliner
Journal:  J Burns Wounds       Date:  2005-01-05

6.  CD4/CD8 ratio and cytokine levels of the BAL fluid in patients with bronchiectasis caused by sulfur mustard gas inhalation.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Inflamm (Lond)       Date:  2007-01-16       Impact factor: 4.981

7.  Cardiopulmonary exercise test findings in symptomatic mustard gas exposed cases with normal HRCT.

Authors:  Rasoul Aliannejad; Amin Saburi; Mostafa Ghanei
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017

8.  Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity induced by sulphur mustard.

Authors:  R Vijayaraghavan; Anshoo Gautam; Manoj Sharma; H T Satish; S C Pant; K Ganesan
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

9.  Human keratinocyte sensitivity towards inflammatory cytokines varies with culture time.

Authors:  G Elliott; D Meent; J Dijk; M Mol
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

10.  Effects of poly (ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur mustard-induced cutaneous injuries in vitro and in vivo.

Authors:  Feng Liu; Ning Jiang; Zhi-Yong Xiao; Jun-Ping Cheng; Yi-Zhou Mei; Pan Zheng; Li Wang; Xiao-Rui Zhang; Xin-Bo Zhou; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  PeerJ       Date:  2016-04-04       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.